I.L.T.-Pharma SRL
I.L.T.-Pharma reported total assets of €2.78m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Dec 2025).
By total assets for 2025, I.L.T.-Pharma ranks among the 500 largest of the 7,454 companies in its sector (NACE 4322) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of I.L.T.-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
I.L.T.-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 230,631 € | ||||
| Equity | 939,798 € | ||||
| Cash | 666,692 € | ||||
| EBITDA | 523,057 € | ||||
| Total assets | €2.78m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 16 Dec 2025
- Year ended 30 Jun 2024filed on 13 Dec 2024
- Year ended 30 Jun 2023filed on 22 Jan 2024
- Year ended 30 Jun 2022filed on 23 Dec 2022
- Year ended 30 Jun 2021filed on 24 Dec 2021
I.L.T.-Pharma's financial analysis
- Solvency33.8%sector median: 51.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of I.L.T.-Pharma
I.L.T.-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.997.178
- VAT number
- BE0457997178
- Peppol
- Registered · 0208:0457997178 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jun 1996
- Registered office
- 2330 Merksplas
- Latest accounts
- 2025 · filed on 16 Dec 2025
- Activity
- Sanitary work (NACE 43221)
I.L.T.-Pharma (SRL) has been based in Merksplas since 1996, active in: sanitary work. For 2025, it reports a net profit of 230,631 € and equity of 939,798 €; its revenue is not published. Its solvency stands at 33.8%, below the median of its sector (51.6%).
Guide: How to check a Belgian building contractor before works →
Companies similar to I.L.T.-Pharma
Companies in the same business, of comparable size and area, outside its group.
- B & S Business and other management consultancy activities Destelbergen · balance sheet €3.04m
- Immotex Business and other management consultancy activities Knokke-Heist · balance sheet €2.67m
- The Management Business and other management consultancy activities Hasselt · balance sheet €2.38m
- Manan Business and other management consultancy activities Lennik · balance sheet €3.44m
- Jurgen Bevers Business and other management consultancy activities Zoersel · balance sheet €2.62m
- ALS Invest Business and other management consultancy activities Lens (Hainaut) · balance sheet €2.21m
- SartiCorp Business and other management consultancy activities Liège · balance sheet €4.35m
- Romareg Business and other management consultancy activities Hamme (Vl.) · balance sheet €1.98m
Frequently asked questions about I.L.T.-Pharma
What is the revenue of I.L.T.-Pharma?
I.L.T.-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of I.L.T.-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0457997178 for I.L.T.-Pharma, if the company is VAT-registered. Its company number (CBE) is 0457.997.178.
Where is the registered office of I.L.T.-Pharma?
According to the CBE register, the registered office of I.L.T.-Pharma is in 2330 Merksplas.
What is the equity of I.L.T.-Pharma?
At the close of the 2025 financial year, the equity of I.L.T.-Pharma amounts to 939,798 €, a solvency of 33.8% of total assets.
Who manages I.L.T.-Pharma?
The register lists 2 active mandates at I.L.T.-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is I.L.T.-Pharma within its sector?
By total assets for 2025, I.L.T.-Pharma ranks among the 500 largest of the 7,454 companies in its sector (NACE 4322) in Belgium that filed accounts for that financial year.
The full file of I.L.T.-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →